The main treatments used for SARS-CoV-2 patients

Simple item page
dc.contributor.authorDjamila, MERGHACHE
dc.date.accessioned2023-05-04T08:03:32Z
dc.date.available2023-05-04T08:03:32Z
dc.date.issued2022-12-30
dc.descriptionarticleen_US
dc.description.abstractAs the COVID-19 pandemic continues to ravage the world and threaten people's lives, treating infected patients effectively has been one of the top concerns for medical workers around the world. Currently, no medication is recommended to treat COVID-19, and no cure is available. Researchers are testing a variety of possible treatments. Several drugs are being researched in different countries. Most are existing drugs that are being trialled against the virus. Pharmaceuticals undergoing clinical trials to assess their safety and efficacy as potential treatments for COVID-19, include the antiviral nucleotide analogue remdesivir, systemic interferons and in particular interferon β-1a, the antiviral combination lopinavir/ritonavir, the antimalarial chloroquine/hydroxychloroquine, and monoclonal antibodies against components of the immune system such as interleukin-6 (IL-6) and IL-4. It is important that the potential treatments are carefully assessed in randomised controlled trials.en_US
dc.identifier.citation.Djamila, MERGHACHE . The main treatments used for SARS-CoV-2 patients. Algerian Journal of Biosciences . Vol 03. N 02. 30/12/2022. University of Eloued .[Write down the date][Copy the download link ]en_US
dc.identifier.issn2773-2916
dc.identifier.urihttp://dspace.univ-eloued.dz/handle/123456789/21653
dc.language.isoenen_US
dc.publisherجامعة الوادي - University of Eloueden_US
dc.subjectSARS-CoV 2, Antivirals, Immunomodulators, Corticosteroid therapy, Plasma therapy.en_US
dc.titleThe main treatments used for SARS-CoV-2 patientsen_US
dc.typeArticleen_US

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
8AJB+(22-015)+MERGHACHE.pdf
Size:
308.86 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

AJP_Vol 03 N 02